Pharmacy

FDA issued a recall of popular blood pressure drugs. Here’s what you need to know.

Making medications more affordable to patients is linked to better adherence, with no added costs, according to a new study.

Surprising findings from the largest study to date investigating the genetics of osteoporosis and fracture risk.

Not all therapies work the same in every patient, but that’s not the biggest challenge in treating mental health. This is.

In response to the lack of transparency, health organizations are creating drug pricing tools that deliver patient-specific pricing. Here’s how they work.

A new forecast reveals an important focus point for healthcare execs in the quest to manage pharma costs.

Here are four other things that MCOs should know about a first-of-its kind targeted RNA-based therapy to treat a rare disease.

Basket trials are designed to test therapies that target a specific genetic mutation found in the tumor, regardless of tumor histology. This emerging trend raises a number of key questions for the industry.

Although the act would not prohibit manufacturers from increasing prices, it could change the pricing landscape. Here’s why.

Managed Healthcare Executive asked key opinion leaders their thoughts on the drug rebate controversy. Here’s what they said.

When it comes to promising areas in the treatment of lymphoma and other blood cancers, gene therapy may be at the top of the list. Here’s why.

Are recent pharma price drops just a response to political pressure or will the momentum last? Managed Healthcare Executive asked industry experts, and here’s what they said.

Amazon captured the industry’s attention once again when it announced it is acquiring online pharmacy PillPack for a reported $1 billion. Here’s how experts say it will affect managed care.

Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.

Prices of more than 20% of generic drugs increased more than 100% between 2010 and 2015.

Recommendations focus on ways to prevent opioid misuse and reduce risk of addiction.

Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.

FDA’s plan to evaluate gene therapies’ impact on surrogate end points is amping up concerns among payers. Here’s why

Trust in the healthcare sector is dropping, a warning sign to executives. Here’s four ways how to reclaim it.

To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.  

Healthcare experts weigh in on the president’s plan to lower drug prices. Here’s what they said.

A Quest Diagnostics study sheds light on Medicare patients with multiple chronic conditions and the top three care gaps.